Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study

N. Maass,Nadia Harbeck,Christoph Mundhenke,Christian Lerchenmüller,Jana Barinoff,Hans Joachim Lück,Johannes Ettl,Bahriye Aktas,Sherko Kümmel,Siegfried Rösel,Steffen Wagner,Lothar Müller,Joachim Bischoff,K Lubbe,Kathrin Schwedler,Marcus Schmidt,Dirk Bauerschlag,Valentina Nekljudova,Gunter von Minckwitz,Sibylle Loibl

Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study

2013

Purpose Everolimus has shown to stop formation and activity of osteoclasts. Breast cancer patients with bone metastases only are candidates for effective but low toxic treatment.

Keywords:

Breast cancer
Everolimus
Metastatic breast cancer
General surgery
Biology
Radiology
Oncology
Internal medicine
Hematology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations